GO
Loading...

Vivus Soars on FDA Panel Support

Thursday, 23 Feb 2012 | 11:55 AM ET

Vivus' obesity/weight-loss drug received overwhelming support from the FDA advisory panel, reports CNBC's Seema Mody.